Roche expanded its global business partnership agreement with Sysmex, under which Roche will continue to offer Sysmex’ hematology products, complementing their total lab solutions portfolio.

The updated non-exclusive agreement also introduces a new area of collaboration with an additional eco-social agreement to jointly explore more sustainable diagnostic solutions.

“We are delighted to expand our 25-year partnership with Sysmex in the area of hematology and in exploring more sustainable diagnostics solutions,” said Matt Sause, CEO of Roche Diagnostics. “Roche and Sysmex both have a long-standing history of delivering reliable and innovative solutions for patients and I am very happy to see this collaboration grow.”

“We are pleased to announce the renewal of our partnership with Roche, reaffirming our commitment to long-term collaboration,” said Kaoru Asano, president of Sysmex Corporation. “Developing our partnerships in the field of diagnostics even further and addressing enduring eco-social challenges represents a significant milestone in advancing our alliance to the next level. Together, we firmly believe in making even greater contributions to our customers in laboratories and creating a sustainable society.”